Regeneron Pharmaceuticals, Inc. (REGN) — Form 10-Q: Quarterly report

Regeneron Pharmaceuticals, Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026. The company reported revenues and net income alongside updates on its commercial products, clinical pipeline, and collaborations. Management discussed ongoing business operations and financial results for the quarter and year-to-date periods.